Voting results pursuant to clause 44(3) of SEBI (LODR) Regulation, 2015 and Scrutinizer''s report for 40th Annual General Meeting of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Ltd held its 40th Annual General Meeting on September 9, 2025, via video conferencing. All four resolutions were passed with 100% approval and zero votes against. The resolutions included adopting audited financial statements for FY ending March 31, 2025, re-appointing director Mr. Rishikesh Thakur (who retires by rotation), ratifying remuneration of cost auditors for FY2025-26, and re-appointing Mrs. Rachna Manav Ghai as Woman Independent Director (special resolution). Out of 6,166 total shareholders, only 44 attended via VC and 2,245,032 votes were polled, representing 50.56% of outstanding shares.
Routine procedural outcome with no dissent — resolutions were passed unanimously among voting shareholders, so no material impact on share price or shareholder value is expected. The re-appointment of directors and approval of financial statements indicates normal governance continuity.